Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Total Debt Over TimeElevated
Percentile Rank100
3Y CAGR+133.7%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
+133.7%/yr
vs -36.6%/yr prior
Acceleration
+170.2pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
12.8x
Strong expansion
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
2024$14.81M+7.2%
2023$13.81M+2949.4%
2022$453000.00-61.0%
2021$1.16M+160.3%
2020$446000.00-
2019$0.00-
2018$0.00-100.0%
2017$7.17M-